Contract 75N93021P01316
Dexorgen Inc. · Department Of Health And Human Services · September 3, 2021
Dexorgen Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 3, 2021 for an undisclosed amount of work in biological product (except diagnostic) manufacturing. Performance is in Gaithersburg, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 6, 2026.
Contract details
- PIID
- 75N93021P01316
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals, Veterinary Use
- Place of performance
- Gaithersburg, MD
- First action
- September 3, 2021
- Latest action
- February 6, 2026
Description
TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Modification timeline
-
February 6, 2026Mod P00001 · Funding Only Action$0
-
September 3, 2021Base awardCELL LINE CONSTRUCTION FOR GPCR RECEPTOR SCREENING$24.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Advanced Technology International | 10 | $225.00M |
| 2 | Sanofi Vaccines Us Inc. | 5 | $27.10M |
| 3 | Meridian Medical Technologies, Llc | 2 | $16.41M |
| 4 | American National Red Cross, The | 12 | $5.59M |
| 5 | Boehringer Ingelheim Animal Health USA Inc | 3 | $3.53M |
| 6 | Versiti Blood Health, Inc. | 12 | $2.52M |
| 7 | American National Red Cross, The | 1 | $1.93M |
| 8 | Miltenyi Biotec, Inc. | 3 | $1.50M |
| 9 | Artemis Technologies Inc | 2 | $983.6K |
| 10 | Oklahoma Blood Institute | 3 | $885.0K |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93021P01316?
Contract 75N93021P01316 is a federal contract awarded to Dexorgen Inc. by Department Of Health And Human Services on September 3, 2021 for an undisclosed amount of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N93021P01316?
Dexorgen Inc. won contract 75N93021P01316 from Department Of Health And Human Services.
How much is contract 75N93021P01316 worth?
Contract 75N93021P01316 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.